Ton Rabelink is Professor of Internal Medicine and Nephrologist at the LUMC. Here, he also heads the department of Internal Medicine. He is Leiden Node Director of the Novo Nordisk Foundation for Stem Cell Medicine, reNEW and figurehead of the theme Regenerative Medicine within the Dutch National Science Agenda. In addition, he’s CSO and co-founder of the LUMC affiliate NecstGen - a non-for-profit Good Manufacturing Practice facility for cell and gene therapy based at Leiden Bio Science Park. Rabelink is co-founder and was kidney-moonshot leader of the public private regenerative medicine consortium RegMedXB, and Chair of the LUMC and Leiden University for the theme Regenerative Medicine. He led the EU Horizon consortium STELLAR, which aimed at developing cellular therapies for kidney disease. In 2024 he was awarded an ERC advanced grant (SPARK) to study the fundamental mechanisms of kidney regeneration.